Osaic Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$288M Buy
312,761
+24,644
+9% +$25M 0.42% 34
2025
Q4
$310M Sell
288,117
-8,946
-3% -$8.55M 0.45% 28
2025
Q3
$220M Buy
297,063
+40,022
+16% +$29.8M 0.31% 49
2025
Q2
$202M Buy
257,041
+34,676
+16% +$26.9M 0.36% 45
2025
Q1
$184M Sell
222,365
-41,673
-16% -$34.7M 0.41% 36
2024
Q4
$155M Buy
264,038
+65,574
+33% +$54.3M 0.35% 48
2024
Q3
$176M Sell
198,464
-4,933
-2% -$4.44M 0.4% 37
2024
Q2
$184M Sell
203,397
-18,428
-8% -$14.7M 0.44% 34
2024
Q1
$173M Sell
221,825
-50,515
-19% -$35.9M 0.39% 35
2023
Q4
$159M Sell
272,340
-86,225
-24% -$50.3M 0.28% 73
2023
Q3
$193M Buy
358,565
+94,140
+36% +$48.5M 0.28% 73
2023
Q2
$124M Sell
264,425
-8,212
-3% -$3.44M 0.22% 92
2023
Q1
$93.8M Sell
272,637
-6,609
-2% -$2.23M 0.18% 120
2022
Q4
$102M Buy
279,246
+19,297
+7% +$6.84M 0.21% 105
2022
Q3
$84.1M Buy
259,949
+18,425
+8% +$5.84M 0.19% 106
2022
Q2
$78.4M Buy
241,524
+28,422
+13% +$8.53M 0.17% 121
2022
Q1
$58.1M Buy
213,102
+16,396
+8% +$4.22M 0.11% 179
2021
Q4
$54.3M Buy
196,706
+10,116
+5% +$2.56M 0.1% 198
2021
Q3
$43.1M Buy
186,590
+14,071
+8% +$3.47M 0.09% 221
2021
Q2
$39.6M Buy
172,519
+120
+0.1% +$24.1K 0.09% 236
2021
Q1
$32.2M Sell
172,399
-2,367
-1% -$463K 0.08% 245
2020
Q4
$29.5M Sell
174,766
-8,666
-5% -$1.29M 0.08% 237
2020
Q3
$27.3M Buy
183,432
+4,739
+3% +$733K 0.08% 229
2020
Q2
$29.4M Sell
178,693
-469,114
-72% -$72M 0.1% 213
2020
Q1
$23.7M Buy
+647,807
New +$89M 0.1% 210

Other funds holding LLY

Osaic Holdings's LLY Position: Q1 2026 in Review

Osaic Holdings increased its Eli Lilly (LLY) stake by 8.6% in Q1 2026, buying an estimated $25M and bringing the position to 312,761 shares worth $288M. The position accounts for 0.42% of the portfolio, ranked #34.

Osaic Holdings first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $310M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Osaic Holdings held 312,761 shares of Eli Lilly worth $288M as of Q1 2026.
  • Osaic Holdings bought 24,644 Eli Lilly shares in Q1 2026, an estimated $25M.
  • Eli Lilly made up 0.42% of Osaic Holdings's portfolio in Q1 2026, its #34 holding.
  • Osaic Holdings first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Eli Lilly position peaked at $310M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.